This inventor holds 1 USPTO granted patent. Top assignee: Alnylam Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Aarti Sharma-Kanning: Innovator in Genetic Research
Introduction
Aarti Sharma-Kanning is a notable inventor based in Tarrytown, GB. She has made significant contributions to the field of genetic research, particularly in the area of RNA agents. Her work has implications for understanding and treating various genetic disorders.
Latest Patents
Aarti holds a patent for "Human Chromosome 9 Open Reading Frame 72 (C9ORF72) iRNA Agent Compositions and Methods of Use Thereof." This patent represents her innovative approach to utilizing RNA agents in genetic research and therapy. She has 1 patent to her name, showcasing her expertise and dedication to advancing scientific knowledge.
Career Highlights
Aarti is currently employed at Alnylam Pharmaceuticals, Inc., a leading company in the field of RNA interference (RNAi) therapeutics. Her role at Alnylam allows her to work on cutting-edge research that has the potential to transform the treatment landscape for genetic diseases.
Collaborations
Aarti collaborates with Elane Fishilevich, a fellow researcher at Alnylam Pharmaceuticals. Their partnership exemplifies the collaborative spirit in scientific research, where diverse expertise can lead to groundbreaking discoveries.
Conclusion
Aarti Sharma-Kanning is a pioneering inventor whose work in genetic research is paving the way for new therapeutic approaches. Her contributions, particularly in RNA agents, highlight the importance of innovation in addressing complex genetic challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile